publication venue for Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study.. 105:1-9. 2008 The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.. 100:39-52. 2008 A direct comparison of research decision-making capacity: schizophrenia/schizoaffective, medically ill, and non-ill subjects.. 99:350-358. 2008 Impairment on the hippocampal-dependent virtual Morris water task in schizophrenia.. 87:67-80. 2006 Olanzapine and haloperidol in first episode psychosis: two-year data.. 86:234-243. 2006 Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.. 83:53-63. 2006 Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode.. 78:161-169. 2005 M50 sensory gating predicts negative symptoms in schizophrenia.. 73:311-318. 2005 An excitement subscale of the Positive and Negative Syndrome Scale.. 68:331-337. 2004 First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.. 66:125-135. 2004 Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels.. 66:31-39. 2004 The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design.. 61:7-18. 2003 The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.. 61:19-30. 2003 Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure.. 58:313-321. 2002 First-episode schizophreniform disorder: comparisons with first-episode schizophrenia.. 46:31-34. 2000 Racial differences in the diagnosis of psychosis.. 21:117-124. 1996 The deficit syndrome in the DSM-IV Field Trial. Part II. Depressive episodes and persecutory beliefs.. 20:79-90. 1996 The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse.. 20:69-77. 1996 Substance abuse in psychotic disorders: associations with affective syndromes. DSM-IV Field Trial Work Group.. 14:73-81. 1994